
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is expected to experience strong growth in the coming years due to its position as a leader in the breast and body-shaping implant market, along with positive financial projections and a "Buy" rating from analysts. However, potential risks such as economic downturn and competition should not be overlooked. Additionally, investors should monitor the company's ability to generate positive free cash flow by the second half of 2026 as it works towards its goal of profitability.
Bears say
Establishment Labs Hldgs is seeing growth in their product sales and adoption, primarily due to increasing demand and utilization of their Motiva implants by plastic surgeons. Despite a recent pullback in shares, the company has a strong potential for long-term revenue growth and free cash flow. However, risks such as economic downturns, competition, and potential complications in the treated population should be considered. Their recent submission for a Motiva label expansion for breast reconstruction also shows potential for future growth, but this may require additional expenses dedicated towards supporting this indication.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares